Tirzepatide Mechanism: How Dual GIP and GLP-1 Receptor Activity Works
A source-led explanation of tirzepatide's engineered structure, dual GIP and GLP-1 receptor activity, signalling bias, and evidence limits.
Read article →Articles on this research topic.
A source-led explanation of tirzepatide's engineered structure, dual GIP and GLP-1 receptor activity, signalling bias, and evidence limits.
Read article →A source-led review of Retatrutide, its GIP, GLP-1 and glucagon receptor activity, Phase 2 evidence, 2026 Phase 3 updates and limitations.
Read article →